194 related articles for article (PubMed ID: 6257389)
1. Phase II evaluation of triazinate in patients with metastatic lung cancer.
Creagan ET; Eagan RT; Fleming TR; Frytak S; Ingle JN; Kvols LK; Nichols WC
Cancer Treat Rep; 1980; 64(10-11):1057-9. PubMed ID: 6257389
[No Abstract] [Full Text] [Related]
2. Hexamethylmelamine in inoperable bronchogenic carcinoma.
Takita H
N Y State J Med; 1972 Feb; 72(4):477-80. PubMed ID: 4334448
[No Abstract] [Full Text] [Related]
3. Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.
Krasnow S; Green M; Perry DJ; Eisenberger MA; Johnston-Early A; Muggia F; Cohen MH
Cancer Treat Rep; 1986 Aug; 70(8):1039-40. PubMed ID: 3524834
[No Abstract] [Full Text] [Related]
4. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
[No Abstract] [Full Text] [Related]
5. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
[No Abstract] [Full Text] [Related]
6. Phase II evaluation of AMSA in patients with metastatic lung cancer.
Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of anaxirone in advanced non-small cell lung cancer.
Fiebig HH; Henss H; Arnold H; von Bültzingslöwen F; Klee M; Queisser W; Peukert M
Cancer Treat Rep; 1987 May; 71(5):539-40. PubMed ID: 3567979
[No Abstract] [Full Text] [Related]
8. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
[No Abstract] [Full Text] [Related]
9. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
[TBL] [Abstract][Full Text] [Related]
10. Phase II study on DON in patients with previously treated advanced lung cancer.
Eagan RT; Frytak S; Nichols WC; Creagan ET; Ingle JN
Cancer Treat Rep; 1982 Aug; 66(8):1665-6. PubMed ID: 6286122
[No Abstract] [Full Text] [Related]
11. Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.
Dhingra HM; Umsawasdi T; Chiuten DF; Murphy WK; Holoye PY; Spitzer G; Valdivieso M
Cancer Treat Rep; 1986 May; 70(5):673-4. PubMed ID: 3708617
[No Abstract] [Full Text] [Related]
12. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
[No Abstract] [Full Text] [Related]
13. Chemotherapy of lung cancer.
Marsh JC
Conn Med; 1975 May; 39(5):283-4. PubMed ID: 165035
[No Abstract] [Full Text] [Related]
14. [Comparative evaluation of the effectiveness of antitumor preparations in human lung cancer xenografts growing on mice in diffusion chambers].
Krutova TV; Korman DB; Potapov IuN; Pashkova VS
Izv Akad Nauk SSSR Biol; 1984; (6):901-8. PubMed ID: 6097608
[No Abstract] [Full Text] [Related]
15. [Nitrullin -- a new original Russian drug of the nitrosomethylurea group].
Gorbunova VA; Orel NF; Semina OV; Besova NS; Kadagidze ZG
Vopr Onkol; 2001; 47(6):680-3. PubMed ID: 11826488
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
Creech RH; Stanley K; Vogl SE; Ettinger DS; Bonomi PD; Salazar O
Cancer Treat Rep; 1982 Jun; 66(6):1417-9. PubMed ID: 6282460
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
Haas CD; Baker L; Thigpen T
Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of pulmonary carcinoma. Considerations and a proposal of a system of the evaluation of clinical course].
Fusaro E; Maccario G; Orlando T; Ghione GL
Minerva Med; 1985 Nov; 76(43):2047-52. PubMed ID: 2999644
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in chemotherapy of lung cancer.
Koven BJ
J Med Soc N J; 1978 Feb; 75(2):155-8. PubMed ID: 202711
[No Abstract] [Full Text] [Related]
20. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
Hutcheon AW; Palmer JB; Pratt MA; Clark RA
Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
